Mechanisms of Action of Combination Motivational Interviewing‐Cognitive Behavior Therapy for Reversing Medication Non‐Adherence in Patients With Multiple Sclerosis
Journal of Clinical Psychology · 2025
DOI: 10.1002/jclp.23796 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Psychology, 2025. Verfasst von Rachel Schoor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Missouri-Kansas City, Kansas City, Missouri, USA. Hauptthemen laut MEDLINE: Motivational Interviewing, Cognitive Behavioral Therapy, Motivation, Medication Adherence. Die Arbeit nennt 59 Literaturangaben. Gefördert von: The parent study was funded with a grant to Dr. Jared Bruce from the National Multiple Sclerosis Society (HC 0138)., National Multiple Sclerosis Society.
Abstract (Originalsprache)
Objective
Despite disease modifying therapies' (DMT) demonstrated efficacy for treating relapsing MS, around 40% of patients discontinue use. This study aimed to understand the mechanism of action of Motivational Interviewing plus cognitive behavioral therapy (MI‐CBT) in a previously conducted randomized controlled trial in which the MI‐CBT intervention successfully promoted DMT re‐initiation of participants compared to a treatment as usual (TAU) condition.
Methods
This secondary analysis ( N = 91) explored changes in motivation (a single item motivation “ruler” [Mot∆], and the Brief Motivation Scale [BMS∆]), autonomous motivation (AR∆), personal control (PC∆), treatment control (TC∆), and confidence to reinitiate (Con∆) as potential mediators of the treatment effect, using logistic regression.
Results
Logistic regression analysis including all potential mediators as predictors of initiation indicated the BMS∆ was the only statistically significant predictor ( OR = 1.61, p = 0.010). When BMS∆ was removed Mot∆ ( OR = 1.22, p = 0.002) and PC∆ ( OR = 1.67, p = 0.002) were statistically significant predictors of initiation.
Conclusion
The MI‐CBT intervention appeared to work primarily by increasing motivation to initiate DMT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, University of Missouri-Kansas City, Kansas City, Missouri, USA.
- Departments of Biomedical and Health Informatics, Neurology, Psychiatry, and University Health, University of Missouri-Kansas City, Kansas City, Missouri, USA.
- Departments of Biostatistics & Epidemiology Core, School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
- Center for Children's Healthy Lifestyles & Nutrition, Children's Mercy Hospital, Kansas City, Missouri, USA.
- Division of Health Services and Outcomes Research, Children's Mercy Hospital, Kansas City, Missouri, USA.
- Department of Pediatrics, University of Kansas Medical Center, Kansas City, Missouri, USA.
Förderung
- The parent study was funded with a grant to Dr. Jared Bruce from the National Multiple Sclerosis Society (HC 0138).
- National Multiple Sclerosis Society
Zitieren
APA
Schoor, R., Bruce, J. M., Staggs, V. S., Fox, A. T., Bruce, A., Lynch, S., & Catley, D. (2025). Mechanisms of Action of Combination Motivational Interviewing‐Cognitive Behavior Therapy for Reversing Medication Non‐Adherence in Patients With Multiple Sclerosis. Journal of Clinical Psychology. https://doi.org/10.1002/jclp.23796
Vancouver
Schoor R, Bruce JM, Staggs VS, Fox AT, Bruce A, Lynch S, et al. Mechanisms of Action of Combination Motivational Interviewing‐Cognitive Behavior Therapy for Reversing Medication Non‐Adherence in Patients With Multiple Sclerosis. Journal of Clinical Psychology. 2025. doi:10.1002/jclp.23796
BibTeX
@article{Schoor2025,
author = {Schoor, Rachel and Bruce, Jared M and Staggs, Vincent S and Fox, Andrew T and Bruce, Amanda and Lynch, Sharon and Catley, Delwyn},
title = {Mechanisms of Action of Combination Motivational Interviewing‐Cognitive Behavior Therapy for Reversing Medication Non‐Adherence in Patients With Multiple Sclerosis},
journal = {Journal of Clinical Psychology},
year = {2025},
doi = {10.1002/jclp.23796}
}
EUVIMED